Ameriprise’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.15M Buy
1,506,379
+128,095
+9% +$432K ﹤0.01% 2411
2025
Q4
$3.9M Buy
+1,378,284
New +$7.11M ﹤0.01% 2607
2025
Q2
Sell
-548,110
Closed -$3.5M 3974
2025
Q1
$3.5M Buy
548,110
+23,609
+5% +$228K ﹤0.01% 2564
2024
Q4
$6.23M Buy
524,501
+79,122
+18% +$1.35M ﹤0.01% 2197
2024
Q3
$12.3M Sell
445,379
-194,998
-30% -$4.88M ﹤0.01% 1629
2024
Q2
$15.3M Sell
640,377
-1,010,573
-61% -$23.7M ﹤0.01% 1442
2024
Q1
$29.1M Sell
1,650,950
-197,570
-11% -$2.91M 0.01% 1074
2023
Q4
$29.2M Buy
1,848,520
+969,028
+110% +$10M 0.01% 1059
2023
Q3
$7.56M Sell
879,492
-97,042
-10% -$689K ﹤0.01% 1936
2023
Q2
$7.7M Buy
976,534
+119,671
+14% +$833K ﹤0.01% 2012
2023
Q1
$6.38M Buy
856,863
+276,345
+48% +$2.75M ﹤0.01% 2140
2022
Q4
$6.84M Buy
580,518
+475
+0.1% +$5.43K ﹤0.01% 2067
2022
Q3
$5.35M Sell
580,043
-42,858
-7% -$519K ﹤0.01% 2173
2022
Q2
$6.15M Buy
+622,901
New +$12.6M ﹤0.01% 2123
2018
Q4
Sell
-434,919
Closed -$1.99M 3650
2018
Q3
$1.99M Buy
434,919
+3,088
+0.7% +$15K ﹤0.01% 2819
2018
Q2
$2.12M Sell
431,831
-199,313
-32% -$946K ﹤0.01% 2713
2018
Q1
$2.69M Sell
631,144
-218,850
-26% -$1.03M ﹤0.01% 2568
2017
Q4
$4.15M Sell
849,994
-136,030
-14% -$634K ﹤0.01% 2258
2017
Q3
$4.29M Buy
986,024
+6,500
+0.7% +$28.4K ﹤0.01% 2198
2017
Q2
$4.36M Sell
979,524
-23,042
-2% -$97.3K ﹤0.01% 2175
2017
Q1
$4.16M Buy
1,002,566
+118,491
+13% +$505K ﹤0.01% 2177
2016
Q4
$3.65M Buy
884,075
+50,960
+6% +$248K ﹤0.01% 2294
2016
Q3
$4.97M Sell
833,115
-39,514
-5% -$199K ﹤0.01% 1997
2016
Q2
$4.34M Buy
872,629
+99,600
+13% +$436K ﹤0.01% 2060
2016
Q1
$3.48M Buy
773,029
+51,170
+7% +$232K ﹤0.01% 2202
2015
Q4
$4.38M Buy
721,859
+305,029
+73% +$2.11M ﹤0.01% 2102
2015
Q3
$3.13M Buy
+416,830
New +$3.03M ﹤0.01% 2330
2014
Q4
Sell
-6,300
Closed -$64K 3732
2014
Q3
$64K Buy
+6,300
New +$63.8K ﹤0.01% 3880

Other funds holding ASPN

Ameriprise's ASPN Position: Q1 2026 in Review

Ameriprise increased its Aspen Aerogels (ASPN) stake by 9.3% in Q1 2026, buying an estimated $432K and bringing the position to 1,506,379 shares worth $5.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2411.

Ameriprise first reported a position in ASPN in Q3 2014 and has held it in 28 quarters since. The position peaked at $29.2M in Q4 2023. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Ameriprise held 1,506,379 shares of Aspen Aerogels worth $5.15M as of Q1 2026.
  • Ameriprise bought 128,095 Aspen Aerogels shares in Q1 2026, an estimated $432K.
  • Aspen Aerogels made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2411 holding.
  • Ameriprise first reported a position in Aspen Aerogels in Q3 2014 and has held it in 28 quarters since.
  • Ameriprise's Aspen Aerogels position peaked at $29.2M in Q4 2023.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.